About
This forum is an educational website developed under the auspices of the University of Glasgow and is dedicated to the dissemination of the latest developments in cytokine signalling. It provides continuing medical education to clinicians around the globe to facilitate greater understanding of the science of cytokines and cytokine signalling, and its implications for clinical practice.
The programmes are free from commercial bias, and feature leading experts sharing their knowledge and experience in the form of video tutorials.
Breaking News
J&J, Protagonist’s oral anti-IL-23 hits main goals in pivotal psoriasis studies
Breaking News
A disease-associated gene desert directs macrophage inflammation through ETS2. See our full slide deck review of this key paper!
Breaking News
Guselkumab Demonstrates Superiority Versus Placebo and Ustekinumab in Phase 3 Crohn’s Disease Program
Breaking News
Gastroenterology Launch is now LIVE! Key Historical Publications and Literature Highlights Available Now
Breaking News
Sarcoidosis Awareness Month
Breaking News
Baricitinib in Juvenile Idiopathic Arthritis: An International, Phase 3, Randomised, Double-blind, Placebo-controlled, Withdrawal, Efficacy, and Safety Trial
Podcasts
Discussing RA: Insights into Filgotinib and Tofacitinib in RA
Podcasts
Discussing AxSpA Podcast: Efficacy and Safety of Upadacitinib
Publications
Secukinumab Reduces Psoriasis-associated Pruritus and Regenerates the Cutaneous Nerve Architecture: Results from PSORITUS a Doubleblind, Placebo-controlled, Randomized Withdrawal Phase IIIb Study
Publications
Interleukin-23 vs. interleukin-12/23 inhibitors on preventing incidental psoriatic arthritis in patients with psoriasis? A real-world comparison from the TriNetX Global Collaborative Network
Podcasts
PsA Podcast: DISCOVER-2 and BE OPTIMAL/BE COMPLETE post-hoc analyses
Publications
Persistent patient-level effect of guselkumab at consecutive 8-week dosing visits and over time in patients with active psoriatic arthritis: post hoc analysis of a 2-year, Phase 3, randomized, controlled study
Podcasts
Discussing RA: Insights into Filgotinib and Tofacitinib in RA
Podcasts
Webinar Highlights Podcast: CAR T-cell Therapy: An Emerging Therapy in Autoimmune Diseases
Publications
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis refractory to biologic therapy: 2-year clinical and radiographic results from the open-label extension of the SELECT-AXIS 2 study
Publications
Tofacitinib safety and effectiveness in Canadian patients with rheumatoid arthritis by cardiovascular risk enrichment: Subanalysis of the CANTORAL study
Publications
Baricitinib as monotherapy for treatment of rheumatoid arthritis: analysis of real-world data
Publications
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Podcasts
AxSpA Podcast: Efficacy and Safety of IV secukinumab
Podcasts
Discussing RA: Navigating JAKis, TNFis, and the quest for optimal RA therapy
Publications
Effect of apremilast on hand and whole-body MRI assessments of inflammation in patients with psoriatic arthritis (MOSAIC): a phase 4, multicentre, single-arm, open-label study
Publications
Deucravacitinib, a selective, TYK2 inhibitor, in psoriatic arthritis: Achievement of minimal disease activity components in a phase 2 trial
Publications
Impact of treatments on fatigue in axial spondyloarthritis: a systematic review and meta-analysis
Podcasts
Author Interview: Derin Karacabeyli, 2024
Podcasts
Webinar Highlights Podcast 2: Evolving Therapeutic Strategies for Psoriatic Diseases
Publications
Efficacy and safety of filgotinib in patients with rheumatoid arthritis: week 156 interim results from a long-term extension study
Publications
A multicentre randomized double-blind placebo-controlled phase III study of the efficacy and safety of xeligekimab (GR1501) in patients with moderate-to-severe plaque psoriasis
Publications
A comparison of the safety and efficacy of tapinarof and roflumilast topical therapies in the management of mild-to-moderate plaque psoriasis
Podcasts
PsA Podcast: Bimekizumab: Efficacy, safety, and effectiveness in PsA
Podcasts
Discussing RA: Long-term safety and efficacy of upadacitinib in SELECT trials
Publications
Efficacy and Safety of Intravenous Secukinumab in Patients With Active Axial Spondyloarthritis: Results From the Randomized, Placebo-Controlled, Phase III INVIGORATE-1 Study
Publications